26
Participants
Start Date
August 2, 2021
Primary Completion Date
March 11, 2022
Study Completion Date
September 15, 2022
LD vehicle-GNP
Two intradermal injections in the upper arm spaced 21 days apart
LD PepGNP-Dengue
Two intradermal injections in the upper arm spaced 21 days apart
HD vehicle-GNP
Two intradermal injections in the upper arm spaced 21 days apart
HD PepGNP-Dengue
Two intradermal injections in the upper arm spaced 21 days apart
Center for Primary Care and Public Health, (Unisante), Lausanne
Lead Sponsor
Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland
OTHER
University of Lausanne Hospitals
OTHER
Gylden Pharma Ltd
INDUSTRY